The Challenges of Psychopharmacogenetics
- 1 September 1999
- journal article
- review article
- Published by Elsevier in American Journal of Human Genetics
- Vol. 65 (3) , 606-610
- https://doi.org/10.1086/302559
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Monoamine Oxidase in Neuropsychiatry and BehaviorAmerican Journal of Human Genetics, 1999
- Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigreesJournal of Psychiatric Research, 1998
- Serotonin Subtype 2 Receptor Genes and Clinical Response to Clozapine in Schizophrenia PatientsNeuropsychopharmacology, 1998
- Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine responseSchizophrenia Research, 1998
- Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotypeThe British Journal of Psychiatry, 1997
- Neuroleptic malignant syndrome and hydroxylase gene mutationsPsychiatric Genetics, 1997
- Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory RegionScience, 1996
- Efficacy and Side-Effects of Clozapine: Testing for Association with Allelic Variation in the Dopamine D4 Receptor GeneNeuropsychopharmacology, 1996
- Allelic Variation of Human Serotonin Transporter Gene ExpressionJournal of Neurochemistry, 1996
- Association between clozapine response and allelic variation in the 5-HT2C receptor geneNeuroReport, 1995